Targeted Delivery of Interferon Gamma Using a Recombinant Fusion Protein of a Fibrin Clot–Binding Peptide With Interferon Gamma for Cancer Gene Therapy
- 8 December 2016
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 106 (3) , 892-897
Abstract
No abstract availableKeywords
Funding Information
- Grant-in-Aid for Scientific Research (B) (24390008)
- Grant-in-Aid for Young Scientists (A) (25713003)
- Grant-in-Aid for JSPS Fellows (12J02931)
- Japan Society for the Promotion of Science
This publication has 27 references indexed in Scilit:
- Selective delivery of IFN‐γ to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosisThe FASEB Journal, 2014
- Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRIBiomaterials, 2013
- Discovery of an uncovered region in fibrin clots and its clinical significanceScientific Reports, 2013
- PEGylation improves pharmacokinetic profile, liver uptake and efficacy of Interferon gamma in liver fibrosisJournal of Controlled Release, 2011
- Nanoparticle-induced vascular blockade in human prostate cancerBlood, 2010
- Biomimetic amplification of nanoparticle homing to tumorsProceedings of the National Academy of Sciences, 2007
- Cancer and venous thromboembolismThe Lancet Oncology, 2005
- Interferon-γ: an overview of signals, mechanisms and functionsJournal of Leukocyte Biology, 2003
- A phase I trial of recombinant gamma interferon in patients with cancerCancer Immunology, Immunotherapy, 1985
- Regulation of Extravascular Coagulation by Microvascular PermeabilityScience, 1985